Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K
What is Genetic Engineering?00:49

What is Genetic Engineering?

73.2K
Overview
73.2K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

424
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
424

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Onion-Bulb Nerve Roots: An Imaging Clue to Charcot-Marie-Tooth Disease Type 1D.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Understanding the rationale for metronidazole use in dogs and cats.

The Journal of small animal practice·2025
Same author

Behavioral, metabolic, and lipidomic characterization of the 5xFADxTg30 mouse model of Alzheimer's disease.

iScience·2024
Same author

Laboratory Study of Collisionless Magnetic Reconnection.

Space science reviews·2023
Same author

Sex and pubertal influences on the neurodevelopmental underpinnings of schizophrenia: A case for longitudinal research on adolescents.

Schizophrenia research·2023
Same author

Hybrid Simulations of the Cusp and Dayside Magnetosheath Dynamics Under Quasi-Radial Interplanetary Magnetic Fields.

Journal of geophysical research. Space physics·2023

Related Experiment Video

Updated: May 26, 2025

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

59.7K

Genetic therapies for movement disorders - current status.

J Sartorelli1,2, J Ng3, A A Rahim4

  • 1Developmental Neurosciences, Zayed Centre for Research Into Rare Disease in Children, UCL Great Ormond Street Institute of Child Health, 20 Guilford Street, London, WC1N 1DZ, UK.

Journal of Neurology
|February 22, 2025
PubMed
Summary

Genetic therapies offer new hope for movement disorders by targeting causative genes. Advances are promising but challenges in safety and delivery remain for conditions like Parkinson's and Huntington's disease.

Keywords:
BrainGeneGenetic therapyMovement disorderViral vector

More Related Videos

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
10:57

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

12.6K
Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord
08:39

Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord

Published on: March 18, 2013

30.3K

Related Experiment Videos

Last Updated: May 26, 2025

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
05:55

Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice

Published on: October 3, 2011

59.7K
Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
10:57

Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons

Published on: July 13, 2015

12.6K
Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord
08:39

Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord

Published on: March 18, 2013

30.3K

Area of Science:

  • Neurology
  • Genetics
  • Molecular Biology

Background:

  • Movement disorders are neurological conditions affecting tone, posture, and voluntary movement.
  • These disorders can be isolated or part of broader multisystemic conditions.
  • Next-generation sequencing has improved understanding of genetic causes and molecular pathways.

Purpose of the Study:

  • To review advances in genetic therapy for movement disorders.
  • To cover both hyperkinetic and hypokinetic conditions.
  • To highlight challenges and future directions in the field.

Main Methods:

  • Literature review of genetic therapy approaches.
  • Focus on conditions including Parkinson's Disease, Huntington's Disease, and rare monogenic disorders.
  • Analysis of current challenges and future research needs.

Main Results:

  • Significant progress has been made in identifying therapeutic targets through genetic research.
  • Genetic therapies are being developed for various hyperkinetic and hypokinetic movement disorders.
  • Several key challenges impede widespread clinical application.

Conclusions:

  • Genetic therapies hold significant potential for treating movement disorders.
  • Safety, toxicity, efficacy, and brain biodistribution are critical challenges to overcome.
  • Future genetic therapies require further research and development to address these limitations.